Stockreport

Immix Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]

Immix Biopharma, Inc.  (IMMX) 
PDF global leader in relapsed/refractory AL Amyloidosis, today announced that it will present and host investor meetings at the following upcoming institutional investor con [Read more]